Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer

NCT00450008 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped PI decision

Conditions

Prostatic Neoplasms

Interventions

DRUG: GM-CSF
DRUG: thalidomide
DRUG: docetaxel

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]